https://www.selleckchem.com/pr....oducts/Decitabine.ht
A significant (P0.001) decrease in cutaneous StO levels from 78.3% (SD 15.3) at baseline to 60.6% (SD 19.8) at the end of occlusion phase was observed, although StO levels returned to baseline after five minutes. Mean cutaneous StO values were similar in the same subjects on separate study days (Pearson R2 0.92 and 0.77, respectively) at both centers. Local vasodilation did not yield significant changes in cutaneous StO values. This pilot study demonstrated the feasibility of a snapshot hyperspectral camera for detecting quantita
Like
Comment
Share
